Skip to main content
. 2011 Jun 23;2(2):419–423. doi: 10.1007/s13148-011-0043-5

Table 3.

Association between the ITIH5 methylation status and cytogenetic findings in the patient cohort

Cytogenetic risk ITIH5 hypermethylation (%)
Total number of patients (n = 104) 14.4% (15/104)
Favorable risk (n = 16) 18.8% (3/16)
 inv(16) (n = 11) 27.3% (3/11)
 t(8;21) (n = 5) 0%
Intermediate risk (n = 60) 11.7% (7/60)
Unfavorable risk (n = 14) 7.1% (1/14)
Karyotype n.a. (n = 14) 28.6% (4/14)

n.a. not available